Behavioral and Biochemical Assays for Autism Models of Wistar Rats
Open Access
- 10 January 2024
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 16 (1) , e52066
Abstract
Being a "behavioral disorder," autism spectrum disorder (ASD) is difficult to manage because its precise etiology is uncertain. In order to better understand the pathophysiology of autism and explore various therapeutic approaches, animal models are developed. Animal models of autism caused by valproate during pregnancy exhibit strong construct validity and reliability. Hence, this study was done among autisminduced rats with the aim of identifying the behavioral and biochemical assays. Pregnant rats were administered sodium valproate on the 12th day of gestation, while control pregnant rats received normal saline. The rats' offspring that received normal saline during intrauterine life were grouped as control, and the rats' offspring that received valproate were grouped as autism -induced. From postnatal day (PND) 21, behavioral assessments were done by using the Y maze (repetitive behavior) and the T maze (social behavior). The estimation of antioxidant profile (malondialdehyde {MDA}, glutathione {GSH}, catalase (CAT), and superoxide dismutase {SOD}), proinflammatory markers (tumor necrosis factor {TNF} alpha, transforming growth factor {TGF} beta, interleukin {IL} 6, and IL -1 beta), neurotransmitters (gammaaminobutyric acid {GABA} and serotonin), and brain -derived neurotrophic factor (BDNF) in the hippocampal region was done. Oxidative stress, increased proinflammatory markers, and increased serotonin were recorded in the autism group. Rats with autism had a significant decrease in GABA and BDNF levels. These biochemical alterations can be correlated with clinical features of autism to diagnose and manage the disorder at the earliest.Keywords
This publication has 22 references indexed in Scilit:
- Autistic‐Like Behaviors, Oxidative Stress Status, and Histopathological Changes in Cerebellum of Valproic Acid Rat Model of Autism Are Improved by the Combined Extract of Purple Rice and Silkworm PupaeOxidative Medicine and Cellular Longevity, 2016
- Role of the Keap1/Nrf2 pathway in neurodegenerative diseasesPathology International, 2015
- Increased BDNF expression in fetal brain in the valproic acid model of autismMolecular and Cellular Neuroscience, 2014
- Alterations of GABAergic Signaling in Autism Spectrum DisordersNeural Plasticity, 2011
- Glutathione pathway gene variation and risk of autism spectrum disordersJournal of Neurodevelopmental Disorders, 2011
- Aberrant NF-KappaB Expression in Autism Spectrum Condition: A Mechanism for NeuroinflammationFrontiers in Psychiatry, 2011
- Decreased GABAB receptors in the cingulate cortex and fusiform gyrus in AutismJournal of Neurochemistry, 2010
- Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autismAutism Research, 2009
- Interaction between BDNF and Serotonin: Role in Mood DisordersNeuropsychopharmacology, 2007
- Is there more to gaba than synaptic inhibition?Nature Reviews Neuroscience, 2002